Q1 2023

Filed May 10, 2023 · 10-Q · 40 days after period end · 0001437749-23-013580

Q1 2023 · 10-Q

Revenue

$64.00K

+6.7% vs Q1 2022

Net Income

-$3.50M

N/M vs Q1 2022

EPS, diluted—

Operating Income-$3,510,000N/M

Operating Cash Flow-$2,560,000N/M

Same quarter

Metric	Q1 2023	Q1 2022	Q1 2021	Q1 2020
Revenue	$64.00K	$60.00K	$46.00K	$38.00K
Net Income	-$3.50M	-$3.33M	-$2.97M	-$4.59M
EPS Diluted	—	—	-$0.18	-$0.67

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR